Market Analysis and Price Projections for Hydrocodone Bitartrate and Acetaminophen (NDC: 71930-0028)
Introduction
Hydrocodone Bitartrate and Acetaminophen, a combination opioid analgesic, is widely used for the treatment of moderate to severe pain. The drug, labeled under the NDC code 71930-0028, is distributed by Eywa Pharma Inc. Here, we will delve into the market analysis and price projections for this medication.
Market Overview of Opioid Drugs
The global opioids drugs market was valued at US$ 27.28 billion in 2022 and is projected to reach US$ 37.24 billion by 2029, growing at a CAGR of 4.54% during the forecast period[4].
Specific Market Dynamics for Hydrocodone Bitartrate and Acetaminophen
- Demand Drivers: The demand for Hydrocodone Bitartrate and Acetaminophen is driven by the rising prevalence of chronic pain and the need for effective pain therapeutics. Regulatory approvals for innovative drug formulations, including abuse-deterrent versions, also contribute to market growth[4].
- Supply Constraints: Recent shortages and discontinuations of certain formulations of Hydrocodone Bitartrate and Acetaminophen, such as those reported in late 2024, can impact market stability and pricing. For instance, Mallinckrodt and Rhodes have faced issues with availability and discontinuation of certain products[5].
Pricing Factors
The pricing of prescription drugs like Hydrocodone Bitartrate and Acetaminophen is influenced by several factors:
- Manufacturing Costs: Research and development costs, as well as obligations to shareholders, play a significant role in determining the final price of the drug[2].
- Regulatory Environment: Changes in regulatory frameworks and the evolving landscape of drug price transparency programs can affect pricing strategies. For example, programs that require reporting of price increases can impact how manufacturers set their prices[2].
- Market Competition: The number of competitors in the market and the effectiveness of the drug compared to alternatives also influence pricing. New brand-name drugs, especially those with limited competition, tend to be more expensive[2].
Price Projections
Given the current market trends and factors influencing pricing:
- Short-Term Projections: In the short term, prices may fluctuate due to supply chain disruptions and shortages. For instance, if there is a shortage of Hydrocodone Bitartrate and Acetaminophen tablets, prices may increase temporarily until supply stabilizes[5].
- Long-Term Projections: Over the long term, the price of Hydrocodone Bitartrate and Acetaminophen is likely to follow the general trend of the opioids drugs market. With a projected CAGR of 4.54%, prices are expected to rise but at a moderate rate. However, this growth could be tempered by increased regulatory scrutiny and efforts to control opioid pricing[4].
Impact of Regulatory Changes
Regulatory changes, such as those related to drug price transparency and the evolving regulatory landscape, will continue to shape the pricing of Hydrocodone Bitartrate and Acetaminophen. For example, programs that provide statutory access to all payer all claims databases can help in better analysis and potentially more controlled pricing[2].
Technological and Clinical Trial Innovations
While not directly impacting the pricing of existing drugs like Hydrocodone Bitartrate and Acetaminophen, innovations in clinical trial designs and the rise of precision medicine could lead to more efficient and cost-effective drug development in the future. This could indirectly influence the market by introducing new, potentially more affordable alternatives[3].
Conclusion
The market for Hydrocodone Bitartrate and Acetaminophen is influenced by a complex interplay of demand drivers, supply constraints, and regulatory factors. Here are some key takeaways:
- Market Growth: The opioids drugs market, including Hydrocodone Bitartrate and Acetaminophen, is expected to grow at a CAGR of 4.54% from 2022 to 2029.
- Pricing Factors: Prices are influenced by manufacturing costs, regulatory environment, and market competition.
- Short-Term Fluctuations: Shortages and supply chain disruptions can cause temporary price increases.
- Long-Term Projections: Prices are expected to rise moderately over the long term, influenced by market growth and regulatory changes.
Key Takeaways
- The global opioids drugs market is growing, driven by increasing demand for pain therapeutics.
- Hydrocodone Bitartrate and Acetaminophen prices are influenced by manufacturing costs, regulatory changes, and market competition.
- Short-term price fluctuations can occur due to supply chain issues.
- Long-term price projections indicate moderate growth.
FAQs
Q: What is the current market size of the global opioids drugs market?
A: The global opioids drugs market was valued at US$ 27.28 billion in 2022[4].
Q: What is the projected growth rate of the opioids drugs market?
A: The market is expected to grow at a CAGR of 4.54% from 2022 to 2029[4].
Q: What factors influence the pricing of Hydrocodone Bitartrate and Acetaminophen?
A: Pricing is influenced by manufacturing costs, regulatory environment, and market competition[2].
Q: Are there any current shortages of Hydrocodone Bitartrate and Acetaminophen?
A: Yes, there have been recent shortages and discontinuations of certain formulations of Hydrocodone Bitartrate and Acetaminophen[5].
Q: How do regulatory changes impact the pricing of opioid drugs?
A: Regulatory changes, such as drug price transparency programs, can affect pricing strategies and potentially lead to more controlled pricing[2].
Sources
- FDA.report - NDC 71930-020 Oral Tablet Hydrocodone Bitartrate and Acetaminophen.
- Oregon Drug Price Transparency Program - Annual Report 2019.
- TFS CRO - 5 Predictions for the Biopharma and Biotech Industries in 2025.
- Maximize Market Research - Global Opioids Drugs Market- Global Industry Analysis and Forecast (2023-2029).
- ASHP - Drug Shortage Detail: Hydrocodone and Acetaminophen Tablets.
